(Q33405296)

English

Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

viral hepatitis

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jing-Houng Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kuo-Chin Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kwong-Ming Kee

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pao-Fei Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yi-Hao Yen

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Po-Lin Tseng

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yuan-Hung Kuo

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ming-Chao Tsai

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chao-Hung Hung

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chien-Hung Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wei-Chen Tai

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lin-San Tsai

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shu-Chuan Chen

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sheng-Che Lin

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sheng-Nan Lu

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

15 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

416-424

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1038/ajg.2012.445

0 references

Primary liver cancer: worldwide incidence and trends

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Issues in screening and surveillance for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: a surveillance study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Hepatocellular Carcinoma: Trends of Incidence and Survival in Europe and the United States at the End of the 20th Century

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.445

21 January 2018

Identifiers

10.1038/AJG.2012.445

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33405296&oldid=1540193991"